LIBRA HuEasy™ AI-based Humanization

ENter

LIBRA OPTM™ antibody Hot-spot de-risk

GeneMedi’s LIBRA OPTM™ is a powerful AI for antibody post-translational modifications (PTM) site de-risking. The LIBRA-OPTM combines sequence and structure-based in silico algorithm with antibody optimization for developing the therapeutic antibody based on post-translational modifications (PTM) site analysis, prediction and de-risking.

auto-derisk